Editor's Picks

There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.

Genentech, Inc.

Genentech, Inc.

  1. FDA warns of counterfeit form of Avastin
    United Press International logo United Press International 3 hours ago
    The American fighter in Libya

    The only FDA-approved version of Avastin for use in the United States is marketed by Genentech, a member company of Roche. The FDA-approved version does not include the Roche logo on the packaging or vials. In addition, Genentech's FDA-approved version...

  2. GOP's Animal Farm War Against Regulations Is Toxic
    Down With Tyranny! logo Down With Tyranny! 7 hours ago

    Tuesday that it is warning doctors, hospitals and patient groups that a counterfeit version of the medicine has been found in the U.S. Tests of counterfeit vials of Avastin showed that they didn't contain the active ingredient in Roche Holding AG's...

  3. AP Photo logo AP Photo 3 days ago
    This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's...

    This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's... View Photo »

  4. Genentech is a global leader in the research and development of innovative medicines, and in combination with our class-leading product engine and deep expertise in chromatin biology, we will create a powerhouse dedicated to bringing the greatest benefit to patients from drugs that modulate epigenetic p...
    SOURCE: Business Wire 1 month ago
  5. Authorities Trace Fake Avastin
    Wall Street Journal logo Wall Street Journal 9 hours ago

    Roche's U.S. unit, Genentech, says it doesn't know whether any patients were given the fake drug. The Food and Drug Administration is investigating, and has sent letters to 19 medical practices, mostly in California, but also in Texas and Illinois,...

  6. Curis to Present at the Citi 2012 Global Healthcare Conference
    iStockAnalyst logo iStockAnalyst 16 hours ago

    Dan Passeri, President and Chief Executive Officer, will provide an overview of Erivedge™ (vismodegib), a hedgehog pathway inhibitor under collaboration with Genentech, a member of the Roche Group. Erivedge is the first FDA-approved medicine for people...

  7. Roche warns of counterfeit cancer drug in US
    The Freeman Chronicles logo The Freeman Chronicles 19 hours ago

    Avastin. The maker of Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche’s Genentech unit says the fake products do not contain the key ingredient in Avastin, which is used to treat cancers of...

  8. AP Photo logo AP Photo 3 days ago
    FILE - This file product image provided by Genentech shows a vial and package for the cancer drug Avastin. A long delayed effort to create an electronic system to weed out counterfeit drugs is likely to get a renewed push after this week's discovery...

    FILE - This file product image provided by Genentech shows a vial and package for the cancer drug Avastin. A long delayed effort to create an electronic system to weed out counterfeit drugs is likely to get a renewed push after this week's discovery... View Photo »

  9. The momentum we already established in R&D is now married with the rigorous scientific input of Genentech, which is well known for its ability to translate scientific benefits to patients
    SOURCE: Xconomy 1 month ago
  10. The Regents of the University of California v. Genentech Inc. - Video Short
    YouTube Logo YouTube Videos 12 months ago
  11. Industry bickers over how to catch fake drugs
    Biloxi Sun Herald logo Biloxi Sun Herald 1 day ago

    But in the meantime the U.S. system continues to be vulnerable to counterfeits, as highlighted by the Avastin case. ASSOCIATED PRESS This file product image provided by Genentech shows a vial and package for the cancer drug Avastin. “This counterfeit...

  12. Janitor arrested for allegedly stealing laptops
    Fresno Bee logo Fresno Bee 1 day ago

    SAN FRANCISCO, Calif. The San Jose Mercury News reports ( http://bit.ly/Afimj5) that Dionisio Dauz was arrested on Feb. 7 for allegedly stealing the computers from the South San Francisco-based biotech firm. San Mateo County Chief Deputy District...

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using Daylife platform, which helps you be more efficient and creative with content. It's designed for publishers, editors, and developers to build better content-based sites, services, and apps for clients and audiences. Learn More »

About Genentech, Inc.

Wikipedia

There are no results for this module. Edit this module to change the search term used to query Wikipedia

Related Photos

This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do...
Pause Play 1/4
prev
  1. This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do... AP Photo logo AP Photo 3 days ago

    This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do...

    View Photo »
  2. In this Dec. 1, 2011 photo, Bruce Roth, Vice President of Discovery Chemistry at Genentech, is photographed on the Genentech campus in South San Francisco, Calif. Lipitor, the best-selling drug in the history of pharmaceuticals, is the blockbuster that almost wasn't. "There was a lot of... AP Photo logo AP Photo 2 months ago

    In this Dec. 1, 2011 photo, Bruce Roth, Vice President of Discovery Chemistry at Genentech, is photographed on the Genentech campus in South San Francisco, Calif. Lipitor, the best-selling drug in the history of pharmaceuticals, is the blockbuster that almost wasn't. "There was a lot of...

    View Photo »
  3. In this Dec. 1, 2011 photo, Bruce Roth, Vice President of Discovery Chemistry at Genentech, is photographed on the Genentech campus in South San Francisco, Calif. "There was a lot of controversy at Warner-Lambert as to whether we should even take our molecule into the clinic" for human... AP Photo logo AP Photo 2 months ago

    In this Dec. 1, 2011 photo, Bruce Roth, Vice President of Discovery Chemistry at Genentech, is photographed on the Genentech campus in South San Francisco, Calif. "There was a lot of controversy at Warner-Lambert as to whether we should even take our molecule into the clinic" for human...

    View Photo »
  4. Venture capitalist Tom Perkins is interviewed in his office in San Francisco, California September 12, 2011. Perkins, co-founder of Kleiner Perkins and the backer of companies ranging from Genentech to Google, believes much of the venture-capital industry has set itself up for failure. ... Reuters Pictures logo Reuters Pictures 5 months ago

    Venture capitalist Tom Perkins is interviewed in his office in San Francisco, California September 12, 2011. Perkins, co-founder of Kleiner Perkins and the backer of companies ranging from Genentech to Google, believes much of the venture-capital industry has set itself up for failure. ...

    View Photo »
next
AP Photo logo AP Photo 3 days ago

This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do...

View Photo »
View All »

Related Topics

  1. Apple, Inc. Apple, Inc.
  2. Avastin
  3. Steve Jobs Steve Jobs
  4. Food and Drug Administration Food and Drug Administration
  5. Breast Cancer Breast Cancer
  6. Pixar Pixar

Timeline of Coverage

  1. Click to see all coverage from Jan 02, 2012
    0
    January 02, 2012
  2. Click to see all coverage from Jan 03, 2012
    15
    January 03, 2012
  3. Click to see all coverage from Jan 04, 2012
    3
    January 04, 2012
  4. Click to see all coverage from Jan 05, 2012
    1
    January 05, 2012
  5. Click to see all coverage from Jan 06, 2012
    3
    January 06, 2012
  6. Click to see all coverage from Jan 07, 2012
    2
    January 07, 2012
  7. Click to see all coverage from Jan 08, 2012
    0
    January 08, 2012
  8. Click to see all coverage from Jan 09, 2012
    9
    January 09, 2012
  9. Click to see all coverage from Jan 10, 2012
    6
    January 10, 2012
  10. Click to see all coverage from Jan 11, 2012
    2
    January 11, 2012
  11. Click to see all coverage from Jan 12, 2012
    1
    January 12, 2012
  12. Click to see all coverage from Jan 13, 2012
    9
    January 13, 2012
  13. Click to see all coverage from Jan 14, 2012
    0
    January 14, 2012
  14. Click to see all coverage from Jan 15, 2012
    0
    January 15, 2012
  15. Click to see all coverage from Jan 16, 2012
    2
    January 16, 2012
  16. Click to see all coverage from Jan 17, 2012
    11
    January 17, 2012
  17. Click to see all coverage from Jan 18, 2012
    4
    January 18, 2012
  18. Click to see all coverage from Jan 19, 2012
    1
    January 19, 2012
  19. Click to see all coverage from Jan 20, 2012
    0
    January 20, 2012
  20. Click to see all coverage from Jan 21, 2012
    0
    January 21, 2012
  21. Click to see all coverage from Jan 22, 2012
    0
    January 22, 2012
  22. Click to see all coverage from Jan 23, 2012
    0
    January 23, 2012
  23. Click to see all coverage from Jan 24, 2012
    1
    January 24, 2012
  24. Click to see all coverage from Jan 25, 2012
    15
    January 25, 2012
  25. Click to see all coverage from Jan 26, 2012
    6
    January 26, 2012
  26. Click to see all coverage from Jan 27, 2012
    1
    January 27, 2012
  27. Click to see all coverage from Jan 28, 2012
    0
    January 28, 2012
  28. Click to see all coverage from Jan 29, 2012
    0
    January 29, 2012
  29. Click to see all coverage from Jan 30, 2012
    80
    January 30, 2012
  30. Click to see all coverage from Jan 31, 2012
    21
    January 31, 2012
  31. Click to see all coverage from Feb 01, 2012
    12
    February 01, 2012
  32. Click to see all coverage from Feb 02, 2012
    2
    February 02, 2012
  33. Click to see all coverage from Feb 03, 2012
    1
    February 03, 2012
  34. Click to see all coverage from Feb 04, 2012
    0
    February 04, 2012
  35. Click to see all coverage from Feb 05, 2012
    1
    February 05, 2012
  36. Click to see all coverage from Feb 06, 2012
    3
    February 06, 2012
  37. Click to see all coverage from Feb 07, 2012
    4
    February 07, 2012
  38. Click to see all coverage from Feb 08, 2012
    4
    February 08, 2012
  39. Click to see all coverage from Feb 09, 2012
    1
    February 09, 2012
  40. Click to see all coverage from Feb 10, 2012
    0
    February 10, 2012
  41. Click to see all coverage from Feb 11, 2012
    0
    February 11, 2012
  42. Click to see all coverage from Feb 12, 2012
    0
    February 12, 2012
  43. Click to see all coverage from Feb 13, 2012
    0
    February 13, 2012
  44. Click to see all coverage from Feb 14, 2012
    15
    February 14, 2012
  45. Click to see all coverage from Feb 15, 2012
    88
    February 15, 2012
  46. Click to see all coverage from Feb 16, 2012
    24
    February 16, 2012
  47. Click to see all coverage from Feb 17, 2012
    6
    February 17, 2012
  48. Click to see all coverage from Feb 18, 2012
    1
    February 18, 2012

Related Videos

  1. Videosurf
    1. Roche Bids $43.7B For Genentech - July 22
      Roche Bids $43.7B For Genentech - July 22
    2. Dr Vinton Cerf Presentation in Brisbane
      Dr Vinton Cerf Presentation in Brisbane
    3. Heroes of Hope
      Heroes of Hope
    4. Les Portes-Tournantes et MortSanto - Le Complot
      Les Portes-Tournantes et MortSanto - Le Complot
      5 months ago
    5. Popular sentiment indicators and how to use them
      Popular sentiment indicators and how to use them
    6. Fda Approves Herceptin® for the Adjuvant Treatment of Her2-Posi
      Fda Approves Herceptin® for the Adjuvant Treatm...
    View All Videosurf Videos »

Related Quotes

  • Previous
  • Next
  • 1/9
  1. Genentech is a global leader in the research and development of innovative medicines, and in combination with our class-leading product engine and deep expertise in chromatin biology, we will create a powerhouse dedicated to bringing the greatest benefit to patients from drugs that modulate epigenetic p...
    SOURCE: Business Wire 1 month ago
  2. The momentum we already established in R&D is now married with the rigorous scientific input of Genentech, which is well known for its ability to translate scientific benefits to patients
    SOURCE: Xconomy 1 month ago
  3. I would really be very pleased to see Genentech pursue those studies, and we would of course be very open to the submission of a new application that would include additional data, including support for the notion of a subset of responders to the use of Avastin
    SOURCE: National Cancer Institute 2 months ago
  4. We are excited about collaborating with Genentech/Roche and The Henry M. Jackson Foundation to explore the combination of NeuVax and Herceptin
    SOURCE: iStockAnalyst 2 months ago
  5. Genentech believes the price for Lucentis is appropriate
    SOURCE: Minyanville 2 months ago
  6. We are hard-pressed to see a scenario where Genentech takes no pricing countermeasures
    SOURCE: Minyanville 2 months ago
  7. Marc is an ideal individual to join the Regeneron board of directors as he is a renowned scientist who also has an outstanding track record for leading drug-discovery programs at Genentech for most of the last decade
    SOURCE: PR Newswire 2 months ago
  8. I encourage Genentech to consider additional studies to identify if there are select subgroups of women suffering from breast cancer who might benefit from this drug
    SOURCE: MedicineNet 2 months ago
  9. While the cannibalization of Roche/Genentech profits (i.e., Avastin and Lucentis) may sound like a market challenge for that company versus a driver for the market, the very availability of these two highly effective, novel medications is expected to continue to drive this previously underserved market ...
    SOURCE: Frost & Sullivan 2 months ago
View All »